Studies on the stability of antitumor protein, neocarzinostatin. I. Stability of solution of neocarzinostatin
Kono, M.; Haneda, I.; Koyama, Y.; Kikuchi, M.
Japanese Journal of Antibiotics 27(6): 707-714
1974
ISSN/ISBN: 0368-2781 PMID: 4282494 Document Number: 76324
Document emailed within 1 workday
Related Documents
Lee, S.H.; Goldberg, I.H. 1988: Role of epoxide in neocarzinostatin chromophore stability and action Molecular Pharmacology 33(4): 396-401Kikuchi, K.; Kusama, S.; Furue, H.; Muto, T.; Toriyama, K.; Wakiya, M. 1983: Clinical evaluation of neocarzinostatin in digestive system cancer. 2. Clinical studies on the administration of neocarzinostatin in advanced and recurrent carcinoma of the pancreas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(8): 1872-1877
Comis, R.L.; Griffin, T.W.; Raso, V.; Ginsberg, S.J. 1979: Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans Cancer Research 39(3): 757-761
Lundgren, P.; Landersjö, L. 1970: Studies on the stability and compatibility of drugs in infusion fluids. II. Factors affecting the stability of benzylpenicillin Acta Pharmaceutica Suecica 7(5): 509-526
Landersjö, L.; Stjernström, G.; Lundgren, P. 1978: Studies on the stability and compatibility of drugs in infusion fluids. V. Effect of lactate and metal ions on the stability of benzylpenicillin Acta Pharmaceutica Suecica 15(3): 161-168
Jira, T.; Pohloudek-Fabini, R. 1983: Analysis and stability of atropine sulfate and scopolamine hydrobromide. 3: Studies on the stability of tropane alkaloids; 80: contribution to problems in the use of plastic containers for liquid pharmaceuticals Die Pharmazie 38(8): 520-523
Seydel, H.; Voigt, R. 1972: Stability of amino acid infusion solutions. 2. Stability of amino acid mixtures in solution Die Pharmazie 27(7): 460-466
Fujita, H.; Nakayama, N.; Sawabe, T.; Kimura, K. 1970: In vivo distribution and inactivation of neocarzinostatin Japanese Journal of Antibiotics 23(5): 471-478
Lin, S.Y.; Kawashima, Y. 1985: Kinetic studies on the stability of indomethacin in alkaline aqueous solution containing poly(oxyethylene)poly(oxypropylene) surface-active block copolymers Pharmaceutica Acta Helvetiae 60(12): 345-350
Rivera, G.; Howarth, C.; Aur, R.J.; Pratt, C.B. 1978: Phase i study of neocarzinostatin in children with cancer Cancer Treatment Reports 62(12): 2105-2107
Kohgo, Y.; Kato, J.; Sasaki, K.; Kondo, H. 1988: Targeting chemotherapy with transferrin-neocarzinostatin conjugate Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-1): 1072-1076
Van Echo, D.A.; Wiernik, P.H. 1978: Phase i study of neocarzinostatin in patients with acute leukemia Cancer Treatment Reports 62(9): 1363-1365
Raso, V. 1977: Radioimmunoassays for methotrexate, citrovorum factor, neocarzinostatin, and actinomycin D Cancer Treatment Reports 61(4): 585-590
Köhnlein, W.; Jung, G. 1982: Neocarzinostatin: molecular mechanism of action and prospects for clinical use Arzneimittel-Forschung 32(11): 1474-1479
Sasada, M.; Sawada, H.; Nakamura, T.; Uchino, H. 1976: Caffeine potentiation on lethality of L-1210 cells treated with neocarzinostatin Gan 67(3): 447-449
Sasaki, Y.; Fujita, S.; Yoshioka, H.; Takimoto, C.; Mitsutani, N.; Koizumi, T. 1982: Efficacy of arterial infusion chemotherapy with neocarzinostatin on inoperable hepatoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 898-905
Tatsumi, K.; Nakamura, T.; Wakisaka, G. 1974: Damage of mammalian cell DNA in vivo and in vitro induced by neocarzinostatin Gan 65(5): 459-461
Ouchi, E.; Honnda, I.; Wakui, A.; Kikuchi, K.; Ishida, N. 1986: The effects of neocarzinostatin on superoxide production by monocyte-derived macrophages Gan no Rinsho. Japan Journal of Cancer Clinics 32(4): 387-391
Rácz, I.; Mezei, J.; Küttel, S. 1986: Stability study of prostacyclin in solution Die Pharmazie 41(11): 769-771
Rácz, I.; Spiegl, P.; Jentzsch, K. 1973: Stability of some curcumin dyes in solution Acta Pharmaceutica Hungarica 43(1): 18-24